Abstract
Fibrous dysplasia is a common benign disorder of bone in which fibro-osseous tissue replaces bone spongiosa. Lesions have a typical appearance on computed tomography (CT) images and regularly show a markedly increased uptake in bone scintigraphy using 99mTc-labelled methylene diphosphonate (99mTc-MDP) as radiotracer. The glucose avidity of these lesions depicted by positron emission tomography (PET) using the radiolabelled glucose derivative 18F-fluoro-2-deoxy-glucose (FDG) is less well known since FDG-PET does not have a role in the assessment of this disease. However, single cases have been reported in which fibrous dysplasia was present in patients undergoing FDG-PET scanning for oncological reasons, and no significant FDG uptake was observed for lesions identified as fibrous dysplasia. We report on a 24-year-old man with known fibrous dysplasia who underwent combined FDG-PET/CT scanning because of suspected recurrence of testicular cancer. In contrast to prior reports, a markedly elevated uptake of FDG was seen in numerous locations that were identified as fibrous dysplasia by CT. Based on this result, we conclude that fibrous dysplasia may mimick malignancy in FDG-PET and that coregistered CT may help to resolve these equivocal findings.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Daffner RH, Kirks DR, Gehweiler JA Jr, Heaston DK (1982) Computed tomography of fibrous dysplasia. Am J Roentgenol 139:943–948
Kransdorf MJ, Moser RP Jr, Gilkey FW (1990) Fibrous dysplasia. Radiographics 10:519–537
Chong VF, Khoo JB, Fan YF (2002) Fibrous dysplasia involving the base of the skull. Am J Roentgenol 178:717–720
Machida K, Makita K, Nishikawa J, Ohtake T, Iio M (1986) Scintigraphic manifestation of fibrous dysplasia. Clin Nucl Med 11:426–429
Johns WD, Gupta SM, Kayani N (1987) Scintigraphic evaluation of polyostotic fibrous dysplasia. Clin Nucl Med 12:627–631
Hardoff R, Eisenberg D, Gross B (1989) Bone scintigraphy in polyostotic fibrous dysplasia resembling multiple bone metastases. Clin Nucl Med 14:928–929
Sathekge MM, Clauss RP (1995) Criteria and quantification of fibrous dysplasia on MDP scanning. Nuklearmedizin 34:229–231
Zhibin Y, Quanyong L, Libo C, Jun Z, Hankui L, Jifang Z, Ruisen Z (2004) The role of radionuclide bone scintigraphy in fibrous dysplasia of bone. Clin Nucl Med 29:177–180
Toba M, Hayashida K, Imakita S et al (1998) Increased bone mineral turnover without increased glucose utilization in sclerotic and hyperplastic change in fibrous dysplasia. Ann Nucl Med 12:153–155
Shigesawa T, Sugawara Y, Shinohara I, Fujii T, Mochizuki T, Morishige I (2005) Bone metastasis detected by FDG PET in a patient with breast cancer and fibrous dysplasia. Clin Nucl Med 30:571–573
Umeoka S, Koyama T, Saga T, Higashi T, Ito N, Kamoto T, Kotani H, Ogawa O, Togashi K (2005) High 18F-fluorodeoxyglocose uptake in adrenal histoplasmosis; a case report. Eur Radiol 15:2483–2486
Rosenbaum SJ, Lind T, Antoch G, Bockisch A (2006) False-Positive FDG PET Uptake-the Role of PET/CT. Eur Radiol 16:1054–1065
Sugaware Y, Fisher SJ, Zasadny KR et al (1998) Preclinical and clinical studies of bone marrow uptake of fluorine-18-fluorodeoxyglucose with or without granulocyte colony-stimulating factor during chemotherapy. J Clin Oncol 16:173–180
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Stegger, L., Juergens, K.U., Kliesch, S. et al. Unexpected finding of elevated glucose uptake in fibrous dysplasia mimicking malignancy: contradicting metabolism and morphology in combined PET/CT. Eur Radiol 17, 1784–1786 (2007). https://doi.org/10.1007/s00330-006-0466-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00330-006-0466-0